{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:39:10Z","timestamp":1791841150708,"version":"4.3.4"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:p>Perioperative anaphylaxis is a rare, but life-threatening hypersensitivity reaction for patients undergoing surgical procedures. Sugammadex is a relatively new drug used to reverse the neuromuscular blockade of specific anesthetics in surgery. Several case reports indicate that there may be a risk of anaphylaxis associated with the use of sugammadex This review examines the literature in order to evaluate the strength of the association between sugammadex use and anaphylaxis. A query of PubMed, EMBASE, and Web of Science was conducted using a combination of terms to identify relevant articles from inception until March 9, 2020. We included any primary study that identified sugammadex as a probable causative agent based on the World Allergy Organization diagnostic criteria for anaphylaxis. A total of 24 articles were reviewed. Across the three randomized controlled trials, there were only four cases of anaphylaxis identified. Incidence of anaphylaxis was reported in only one trial at 0.33%. Two retrospective observational studies conducted in Japan identified cases of anaphylaxis, with incidences of 0.02 and 0.04%. Among 19 case reports and series, 25 patient cases of anaphylaxis were confirmed via allergy testing to be caused by sugammadex or sugammadex\u2013rocuronium complex. Commonly reported symptoms included hypotension, erythema, and decreased oxygen saturation. Based on the findings of this review, there appears to be a rare, but serious, association of sugammadex-induced perioperative anaphylaxis with an incidence between 0.02 and 0.04% in observational studies. It is unclear whether sugammadex on its own or in complex with rocuronium triggers this reaction, but it is clearly involved in inducing anaphylaxis. Further population studies are needed to get a more accurate global incidence rate, and more detailed allergy testing is required to better describe which step of the sugammadex reversal pathway initiates the anaphylactic attack.<\/jats:p>","DOI":"10.4103\/joacp.joacp_573_20","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T11:28:33Z","timestamp":1665487713000},"page":"360-370","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":26,"title":["Sugammadex-induced anaphylactic reaction: A systematic review"],"prefix":"10.4103","volume":"38","author":[{"given":"Fatih","family":"Zecic","sequence":"first","affiliation":[{"name":"Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary H.","family":"Smart","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor C.","family":"Abbey","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Pazhempallil","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Korban","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.lpm.2016.02.024","article-title":"Epidemiology of perioperative anaphylaxis","volume":"45","author":"Mertes","year":"2016","journal-title":"Presse Med"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bja\/aet117","article-title":"Survival from perioperative anaphylaxis in Western Australia 2000-2009","volume":"111","author":"Gibbs","year":"2013","journal-title":"Br J Anaesth"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaci.2011.03.003","article-title":"Anaphylaxis during anesthesia in France:An 8-year national survey","volume":"128","author":"Mertes","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bja.2018.07.014","article-title":"Sugammadex:The sting in the tail?","volume":"121","author":"Savic","year":"2018","journal-title":"Br J Anaesth"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/14740338.2019.1649393","article-title":"Safety of sugammadex for reversal of neuromuscular block","volume":"18","author":"Honing","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"R8-20240828","first-page":"266","article-title":"A novel concept of reversing neuromuscular block:Chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host","volume":"41","author":"Bom","year":"2002","journal-title":"Angew Chem Int Ed Engl"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1515\/jccm-2016-0005","article-title":"Sugammadex:An update","volume":"2","author":"Ezri","year":"2016","journal-title":"J Crit Care Med (Targu Mures)"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jclinane.2011.04.015","article-title":"Successful management of rocuronium-induced anaphylactic reactions with sugammadex:A case report","volume":"24","author":"Kawano","year":"2012","journal-title":"J Clin Anesth"},{"key":"R11-20240828","article-title":"Drug hypersensitivity:Classification and clinical features","author":"Pichler","journal-title":"UpToDate"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/anae.12736","article-title":"Hypersensitivity associated with sugammadex administration:A systematic review","volume":"69","author":"Tsur","year":"2014","journal-title":"Anaesthesia"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.bja.2018.05.056","article-title":"Hypersensitivity incidence after sugammadex administration in healthy subjects:A randomised controlled trial","volume":"121","author":"Min","year":"2018","journal-title":"Br J Anaesth"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bja.2018.05.057","article-title":"Sugammadex hypersensitivity and underlying mechanisms:A randomised study of healthy non-anaesthetised volunteers","volume":"121","author":"de Kam","year":"2018","journal-title":"Br J Anaesth"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/BF03256915","article-title":"Safety, tolerability and pharmacokinetics of sugammadex using single high doses (Up to 96 mg\/kg) in healthy adult subjects a randomized, double-blind, crossover, placebo-controlled, single-centre study","volume":"30","author":"Peeters","year":"2010","journal-title":"Clin Drug Invest"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.annemergmed.2006.01.018","article-title":"Second symposium on the definition and management of anaphylaxis:Summary report--second National institute of allergy and infectious disease\/Food allergy and anaphylaxis network symposium","volume":"47","author":"Sampson","year":"2006","journal-title":"Ann Emerg Med"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis:Case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"R\u00fcggeberg","year":"2007","journal-title":"Vaccine"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1213\/ANE.0000000000002562","article-title":"Incidence of anaphylaxis associated with sugammadex","volume":"126","author":"Miyazaki","year":"2018","journal-title":"Anesth Analg"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bja.2019.10.016","article-title":"Comparison of incidence of anaphylaxis between sugammadex and neostigmine:A retrospective multicentre observational study","volume":"124","author":"Orihara","year":"2020","journal-title":"Br J Anaesth"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/WOX.0b013e318211496c","article-title":"World allergy organization guidelines for the assessment and management of anaphylaxis","volume":"4","author":"Simons","year":"2011","journal-title":"World Allergy Organ J"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"bcr2017220197","DOI":"10.1136\/bcr-2017-220197","article-title":"A confirmed case of sugammadex-induced anaphylaxis in a UK hospital","volume":"2017","author":"O'Donnell","year":"2017","journal-title":"BMJ Case Rep"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40981-020-00326-7","article-title":"A rare case of atropine-resistant bradycardia following sugammadex administration","volume":"6","author":"Yoshida","year":"2020","journal-title":"JA Clin Rep"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00540-016-2280-4","article-title":"A suspected case of rocuronium-sugammadex complex-induced anaphylactic shock after cesarean section","volume":"31","author":"Yamaoka","year":"2017","journal-title":"J Anesth"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2044.2010.06611.x","article-title":"Allergy to low dose sugammadex","volume":"66","author":"Menendez-Ozcoidi","year":"2011","journal-title":"Anaesthesia"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1213\/XAA.0000000000000774","article-title":"Anaphylactic reactions to native and light-exposed sugammadex suggested by Basophil activation test:A report of 2 cases","volume":"11","author":"Yamada","year":"2018","journal-title":"A A Pract"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4097\/kja.d.18.00232","article-title":"Anaphylactic shock after sugammadex administration, induced by formation of a sugammadex-rocuronium complex -a case report","volume":"72","author":"Kim","year":"2019","journal-title":"Korean J Anesthesiol"},{"key":"R28-20240828","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4097\/kja.19344","article-title":"Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report","volume":"73","author":"Choi","year":"2020","journal-title":"Korean J Anesthesiol"},{"key":"R29-20240828","first-page":"e3871","article-title":"Anaphylaxis induced by sugammadex in a patient with papillary serous carcinoma of the uterine adnexa undergoing exploratory laparotomy","volume":"11","author":"Escher","year":"2019","journal-title":"Cureus"},{"key":"R30-20240828","doi-asserted-by":"crossref","first-page":"e9661","DOI":"10.1097\/MD.0000000000009661","article-title":"Clinically suspected anaphylaxis induced by sugammadex in a patient with Weaver syndrome undergoing restrictive mammoplasty surgery:A case report with the literature review","volume":"97","author":"Bedirli","year":"2018","journal-title":"Medicine"},{"key":"R31-20240828","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.aat.2012.08.010","article-title":"Hypersensitivity reaction probably induced by sugammadex","volume":"50","author":"Asahi","year":"2012","journal-title":"Acta Anaesthesiol Taiwan"},{"key":"R32-20240828","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/0310057X1404200116","article-title":"Intraoperative anaphylaxis to sugammadex and a protocol for intradermal skin testing","volume":"42","author":"Sadleir","year":"2014","journal-title":"Anaesth Intensive Care"},{"key":"R33-20240828","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.anai.2016.09.428","article-title":"Sugammadex:An emerging trigger of intraoperative anaphylaxis","volume":"117","author":"Ue","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R34-20240828","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4097\/kjae.2016.69.4.413","article-title":"Suspected anaphylactic reaction associated with sugammadex:A case report","volume":"69","author":"Yoo","year":"2016","journal-title":"Korean J Anesthesiol"},{"key":"R35-20240828","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2253-14-92","article-title":"Three suspected cases of sugammadex-induced anaphylactic shock","volume":"14","author":"Takazawa","year":"2014","journal-title":"BMC Anesthesiol"},{"key":"R36-20240828","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1213\/XAA.0000000000000382","article-title":"The first case report of anaphylaxis caused by the inclusion complex of rocuronium and sugammadex","volume":"7","author":"Ho","year":"2016","journal-title":"A A Case Rep"},{"key":"R37-20240828","first-page":"163","article-title":"Timing of sugammadex administration:A case report","volume":"19","author":"Frenkel","year":"2015","journal-title":"Anaesth Pain Intensi"},{"key":"R38-20240828","first-page":"6590101","article-title":"Two cardiac arrests that occurred after the administration of sugammadex:A case of Kounis syndrome","volume":"2020","author":"Yanai","year":"2020","journal-title":"Case Rep Emerg Med"},{"key":"R39-20240828","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/bja\/aes137","article-title":"Three cases of suspected sugammadex-induced hypersensitivity reactions","volume":"109","author":"Godai","year":"2012","journal-title":"Br J Anaesth"},{"key":"R40-20240828","first-page":"66","article-title":"Sugammadex-induced hypersensitivity reaction in a pediatric patient","volume":"46","author":"Colak","year":"2018","journal-title":"Turk J Anaesthesiol Reanim"},{"key":"R41-20240828","article-title":"Current status of sugammadex usage and the occurrence of sugammadex-induced anaphylaxis in Japan","volume":"33","author":"Takazawa","year":"2018","journal-title":"J Anesth Patient Saf Found"},{"key":"R42-20240828","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2:A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R43-20240828","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I:A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"R44-20240828","first-page":"442","article-title":"Reducing the risk of anaphylaxis during anesthesia:2011 updated guidelines for clinical practice","volume":"21","author":"Mertes","year":"2011","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R45-20240828","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","article-title":"General considerations for skin test procedures in the diagnosis of drug hypersensitivity","volume":"57","author":"Brockow","year":"2002","journal-title":"Allergy"}],"container-title":["Journal of Anaesthesiology Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/joacp.JOACP_573_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:13:00Z","timestamp":1787757180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/joacp.JOACP_573_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/joacp.joacp_573_20","relation":{},"ISSN":["2231-2730","0970-9185"],"issn-type":[{"value":"2231-2730","type":"print"},{"value":"0970-9185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,8]]},"assertion":[{"value":"2020-09-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}